We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Novel Device Measures Glucose in Urine

By LabMedica International staff writers
Posted on 01 Dec 2015
A device has been developed that can measure glucose in blood through the urine in the toilet, and it activates via smart phone bluetooth, recording the values on a daily basis.

One of the values taken into account for the design was the pain caused by the use of needles for monitoring glucose in blood, which is partly responsible of why patients with diabetes do not keep proper control of their disease.

Two young technologists at the Chihuahua Institute of Technology (Mexico) developed the device which has achieved international recognition, included being one of the 10 most outstanding creations among innovators under 35 delivered by the MIT Tech Review; it also won the Global Innovation Competition for Science and Technology for the Benefit of Mankind (GIST Tech-I), an initiative promoted by the US President, where the team competed against 900 technological developments from all over the world. More...


The device is called the Glucosalarm (Brownsville, TX, USA) and it uses two 70 mL bottles, one contains an enzyme and the other one contains a cleaning solution, which last for 140 measurements and are easily replaceable. The device uses a light sensor that detects the frequency of glucose in urine and measures it in 15 to 40 seconds. Only one drop of urine is needed and this can be done when the patient uses the toilet and there is no need for painful blood testing. Another reason for not having a constant monitoring is the cost. A glucometer costs less than USD 30, but the test strips are expensive, as well as needles and needle holders, which is money that is not available to everyone. Glucosalarm will cost approximately USD 120 to USD 140 and the readings will cost less than a penny per measurement.

Currently, the device is in the third prototype and tests are performed with patients. It also has a patent in Mexico and the United States, and two medical device companies with international presence have shown interest in manufacturing it. Glucosalarm is expected to be released in the USA and Mexico in late 2016 and early 2017, once the necessary authorizations are obtained from the US Food and Drug Administration (FDA, Silver Springs, MD, USA) and the Mexican Federal Commission for the Protection against Sanitary Risk (COFEPRIS; Benito Juárez, Mexico).

Related Links:

Chihuahua Institute of Technology
GlucosAlarm 
US Food and Drug Administration 



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
DNA/RNA Extraction/Purification Kit
Nucleic Acid Extraction or Purification Kit
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.